Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Assets (2023 - 2025)

Profound Medical (PROF) has 3 years of Non-Current Assets data on record, last reported at $1.4 million in Q4 2025.

  • For Q4 2025, Non-Current Assets rose 18.56% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $4.0 million, changed N/A, while the annual FY2025 figure was $1.4 million, 18.56% up from the prior year.
  • Non-Current Assets reached $1.4 million in Q4 2025 per PROF's latest filing, up from $781000.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.1 million in Q4 2023 and bottomed at $781000.0 in Q3 2025.
  • Average Non-Current Assets over 3 years is $1.2 million, with a median of $1.1 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: tumbled 43.25% in 2024, then increased 18.56% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $2.1 million in 2023, then crashed by 43.25% to $1.2 million in 2024, then increased by 18.56% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $1.4 million in Q4 2025, $781000.0 in Q3 2025, and $857000.0 in Q2 2025.